{"id":338622,"date":"2026-11-04T11:29:12","date_gmt":"2026-11-04T05:59:12","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/global-health-q2-results-fy27-pat-219-crore\/"},"modified":"2026-11-04T11:29:12","modified_gmt":"2026-11-04T05:59:12","slug":"global-health-q2-results-fy27-pat-219-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/global-health-q2-results-fy27-pat-219-crore\/","title":{"rendered":"Global Health Q2 Results FY27: PAT Rises 38.35% to Rs 219.14 Cr, Revenue Rs 1,469.04 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Global Health Q2 Results FY27 were declared on 3 November 2026. The quarterly results on a Consolidated basis show revenue of Rs 1,469.04 Cr, up 33.64% from Rs 1,099.22 Cr a year earlier, and net profit of Rs 219.14 Cr, up 38.35% from Rs 158.40 Cr. This YoY growth was led by Operating Profit, which rose 60.25% to Rs 370.09 Cr.<\/p>\n<\/div>\n

Global Health Ltd (MEDANTA) Q2 Results FY27 announced on 3 November 2026, covering the company’s financial performance for the July to September quarter. Under Global Health Q2 Results FY27, the company posted Consolidated revenue of Rs 1,469.04 Cr and a net profit of Rs 219.14 Cr. The results date of 3 November 2026 puts these consolidated results in the public domain on NSE and BSE.<\/p>\n

This Global Health Q2 Results results analysis looks at how revenue, Operating Profit and net profit moved against the same quarter a year ago. It then covers the business factors, the FY27 outlook and the risks, and the Univest Screener tracks the same MEDANTA figures. The Financial Highlights section comes first.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n